Cargando…
Adalimumab-Induced Erythema Multiforme in a Patient With Rheumatoid Arthritis: A Case Report
Tumor necrosis factor-alpha (TNF-α) inhibitors are a group of biological medications that revolutionized the treatment of rheumatoid arthritis (RA) and several other inflammatory autoimmune diseases. The wide use of these drugs has been associated with some adverse reactions. Erythema multiforme (EM...
Autores principales: | Mohammed, Jinan Q, Mahmmod, Zainab, Mathkhor, Abdulsatar J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752112/ https://www.ncbi.nlm.nih.gov/pubmed/35036238 http://dx.doi.org/10.7759/cureus.21126 |
Ejemplares similares
-
Erythema Dyschromicum Perstans After Adalimumab Treatment
por: Alsisi, Ghazal G, et al.
Publicado: (2022) -
Variants of Erythema Multiforme: A Case Report and Literature Review
por: Paulino, Luis, et al.
Publicado: (2018) -
Recurrent Erythema Multiforme Induced by the Combination of Pembrolizumab and Radiation
por: Ambur, Austin B, et al.
Publicado: (2021) -
Dermatologic and Ophthalmologic Treatment of Erythema Multiforme Major: A Case Report
por: Senger, Barbara, et al.
Publicado: (2021) -
Secondary Syphilis Presenting as Erythema Multiforme in the Setting of AIDS and Psoriasis
por: Cook, Olivia M, et al.
Publicado: (2022)